|Classification and external resources|
Nezelof syndrome (also known as "Thymic dysplasia with normal immunoglobulins":85) is an autosomal recessive congenital immunodeficiency condition due to underdevelopment of the thymus. An association with CD44 has been proposed.
The defect is an inactive purine nucleoside phosphorylase. This results in an accumulation of deoxy-GTP which inhibits ribonucleotide reductase. Ribonucleotide reductase catalyzes the formation of deoxyribonucleotides from ribonucleotides. Thus, DNA replication is inhibited and cells cannot replicate.
It was characterized in 1964.
It causes severe infections and malignancies. it is characterized by elevated immunoglobulins that function poorly.
- James, William D.; Berger, Timothy G.; et al. (2006). Andrews' Diseases of the Skin: clinical Dermatology. Saunders Elsevier. ISBN 0-7216-2921-0.
- Online 'Mendelian Inheritance in Man' (OMIM) 242700
- Knutsen AP, Wall D, Mueller KR, Bouhasin JD (May 1996). "Abnormal in vitro thymocyte differentiation in a patient with severe combined immunodeficiency-Nezelof's syndrome". J. Clin. Immunol. 16 (3): 151–8. doi:10.1007/BF01540913. PMID 8734358.
- Nezelof C, Jammet ML, Lortholary P, Labrune B, Lamy M (Oct 1964). "Hereditary Thymic Hypoplasia: Its Place And Responsibility In A Case Of Lymphocytic, Normoplasmocytic And Normoglobulinemic Aplasia In An Infant". Archives francaises de pediatrie 21: 897–920. ISSN 0003-9764. PMID 14195287.
|This article about a disease of the blood or immune system is a stub. You can help Wikipedia by expanding it.|